134 related articles for article (PubMed ID: 23287887)
21. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids].
Hänggi W; Birkhäuser MH; Malek A; Peheim E; von Hospenthal JU
Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155
[TBL] [Abstract][Full Text] [Related]
22. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
23. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
24. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
Prázný M; Fait T; Vrablik M
Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
[TBL] [Abstract][Full Text] [Related]
25. The effects of different doses of medroxyprogesterone acetate on serum lipids, lipoprotein levels and atherogenic index in the menopausal period.
Aygen EM; Başbuğ M; Tayyar M; Kaya E
Gynecol Endocrinol; 1998 Aug; 12(4):267-72. PubMed ID: 9798136
[TBL] [Abstract][Full Text] [Related]
26. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
[TBL] [Abstract][Full Text] [Related]
27. Menopause and modifiable coronary heart disease risk factors: a population based study.
Agrinier N; Cournot M; Dallongeville J; Arveiler D; Ducimetière P; Ruidavets JB; Ferrières J
Maturitas; 2010 Mar; 65(3):237-43. PubMed ID: 20031345
[TBL] [Abstract][Full Text] [Related]
28. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
Grisar J; Travica S; Metka M; Pietschmann P
Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
[TBL] [Abstract][Full Text] [Related]
29. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
30. [The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].
Pirat B; Korkmaz ME; Eroğlu S; Tayfun E; Yildirir A; Uluçam M; Ozin B; Müderrisoğlu H
Anadolu Kardiyol Derg; 2004 Dec; 4(4):318-22. PubMed ID: 15590360
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
Tugrul S; Yildirim G; Pekin O; Uslu H; Kutlu T; Eren S
Arch Gynecol Obstet; 2007 May; 275(5):335-9. PubMed ID: 17051405
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol and atherosclerosis: modulation by oestrogen.
Barton M
Curr Opin Lipidol; 2013 Jun; 24(3):214-20. PubMed ID: 23594711
[TBL] [Abstract][Full Text] [Related]
33. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
34. Effect of oestrogen replacement therapy on serum lipid profile.
Nanda S; Gupta N; Mehta HC; Sangwan K
Aust N Z J Obstet Gynaecol; 2003 Jun; 43(3):213-6. PubMed ID: 14712987
[TBL] [Abstract][Full Text] [Related]
35. The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
Tadmor OP; Kleinman Y; Goldstein R; Diamant YZ
Int J Gynaecol Obstet; 1992 Oct; 39(2):105-10. PubMed ID: 1358708
[TBL] [Abstract][Full Text] [Related]
36. Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy.
Rajman I; Lip GY; Cramb R; Maxwell SR; Zarifis J; Beevers DG; Kendall MJ
QJM; 1996 Oct; 89(10):771-8. PubMed ID: 8944233
[TBL] [Abstract][Full Text] [Related]
37. Short-term effects and safety of a natural oral supplement containing glucosinolates, phytosterols, and citrus flavonoids compared with hormone treatment for the management of postmenopausal symptomatic women: a pilot single-center randomized phase 2 clinical trial.
Villar-López M; Soto-Becerra P; Chedraui P; Osorio-Manyari JD; Al-Kassab-Córdova A; Osorio-Manyari AA; Fernandez-Sosaya JL; Moya-Silvestre E; Rojas PA; Lugo-Martínez G; Mezones-Holguín E
Menopause; 2023 Dec; 30(12):1230-1240. PubMed ID: 37874969
[TBL] [Abstract][Full Text] [Related]
38. Plasma lipid and lipoprotein profiles in pre- and post-menopausal middle-aged runners.
Higuchi M; Iwaoka K; Ishii K; Matsuo S; Kobayashi S; Tamai T; Takai H; Nakai T
Clin Physiol; 1990 Jan; 10(1):69-76. PubMed ID: 2302937
[TBL] [Abstract][Full Text] [Related]
39. Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women.
Hall G; Collins A; Csemiczky G; Landgren BM
Maturitas; 2002 Mar; 41(3):177-85. PubMed ID: 11886763
[TBL] [Abstract][Full Text] [Related]
40. Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study.
Delitala AP; Steri M; Pilia MG; Dei M; Lai S; Delitala G; Schlessinger D; Cucca F
Maturitas; 2016 Oct; 92():30-34. PubMed ID: 27621235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
